These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2145433)

  • 21. Synthesis and quantitative structure-activity relationships of diclofenac analogues.
    Moser P; Sallmann A; Wiesenberg I
    J Med Chem; 1990 Sep; 33(9):2358-68. PubMed ID: 2118185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of antiinflammatory actions of curcumine and boswellic acids.
    Ammon HP; Safayhi H; Mack T; Sabieraj J
    J Ethnopharmacol; 1993 Mar; 38(2-3):113-9. PubMed ID: 8510458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antiinflammatory activity of coumarin derivatives.
    Kontogiorgis CA; Hadjipavlou-Litina DJ
    J Med Chem; 2005 Oct; 48(20):6400-8. PubMed ID: 16190766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
    Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors.
    Unangst PC; Shrum GP; Connor DT; Dyer RD; Schrier DJ
    J Med Chem; 1992 Oct; 35(20):3691-8. PubMed ID: 1433181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antiinflammatory action of guanabenz is mediated through 5-lipoxygenase and cyclooxygenase inhibition.
    Chang J; Blazek E; Skowronek M; Marinari L; Carlson RP
    Eur J Pharmacol; 1987 Oct; 142(2):197-205. PubMed ID: 3121363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonsteroidal antiinflammatory agents, XVII: Inhibition of bovine cyclooxygenase and 5-lipoxygenase by N-alkyldiphenyl-pyrrolyl acetic and propionic acid derivatives.
    Dannhardt G; Lehr M
    Arch Pharm (Weinheim); 1993 Mar; 326(3):157-62. PubMed ID: 8481094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzimidazole derivatives with atypical antiinflammatory activity.
    Lazer ES; Matteo MR; Possanza GJ
    J Med Chem; 1987 Apr; 30(4):726-9. PubMed ID: 3104589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel antiinflammatory analgesics: 3-(2-/4-pyridylethyl)-benzoxazolinone and oxazolo[4,5-b]pyridin-2-one derivatives.
    Gökhan N; Erdogan H; Durlu T; Demirdamar R
    Arch Pharm (Weinheim); 1999 Feb; 332(2):43-9. PubMed ID: 10191713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
    Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
    Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity.
    Hamer RR; Tegeler JJ; Kurtz ES; Allen RC; Bailey SC; Elliott ME; Hellyer L; Helsley GC; Przekop P; Freed BS; White J; Martin LL
    J Med Chem; 1996 Jan; 39(1):246-52. PubMed ID: 8568814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)- 4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity.
    Unangst PC; Connor DT; Cetenko WA; Sorenson RJ; Kostlan CR; Sircar JC; Wright CD; Schrier DJ; Dyer RD
    J Med Chem; 1994 Jan; 37(2):322-8. PubMed ID: 8295221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cdc7 kinase inhibitors: pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationships.
    Vanotti E; Amici R; Bargiotti A; Berthelsen J; Bosotti R; Ciavolella A; Cirla A; Cristiani C; D'Alessio R; Forte B; Isacchi A; Martina K; Menichincheri M; Molinari A; Montagnoli A; Orsini P; Pillan A; Roletto F; Scolaro A; Tibolla M; Valsasina B; Varasi M; Volpi D; Santocanale C
    J Med Chem; 2008 Feb; 51(3):487-501. PubMed ID: 18201066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
    Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pyrrolo(2,3-c)quinolines and pyrrolo(3,4-d)quinolines--synthesis and investigation of lipoxygenase inhibition].
    Görlitzer K; Fabian J; Frohberg P; Drutkowski G
    Pharmazie; 2002 Apr; 57(4):243-9. PubMed ID: 11998442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives.
    Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Murakami M; Oketani K; Inoue T
    J Med Chem; 1994 Sep; 37(19):3062-70. PubMed ID: 7932529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actions of a 5-lipoxygenase inhibitor, Sch 40120, on acute inflammatory responses.
    Smith SR; Watnick AW; Bryant RW; Billah M; Siegel MI
    J Pharmacol Exp Ther; 1992 Aug; 262(2):721-8. PubMed ID: 1386887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents.
    Khanna IK; Yu Y; Huff RM; Weier RM; Xu X; Koszyk FJ; Collins PW; Cogburn JN; Isakson PC; Koboldt CM; Masferrer JL; Perkins WE; Seibert K; Veenhuizen AW; Yuan J; Yang DC; Zhang YY
    J Med Chem; 2000 Aug; 43(16):3168-85. PubMed ID: 10956225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-aminoalkyloxazolo[4,5-b]pyridin-2(3H)-ones: synthesis and evaluation of antinoceptive activity.
    Savelon L; Bizot-Espiard JG; Caignard DH; Pfeiffer B; Renard P; Viaud MC; Guillaumet G
    Bioorg Med Chem; 1998 Nov; 6(11):1963-73. PubMed ID: 9881089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.